Septerna, Inc. (SEPN) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Septerna, Inc. (SEPN) closed at USD 36.32 on 2026-10-14, a change of +62.7 % over the past year, with a market capitalization of USD 1.75B.

Septerna, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Septerna, Inc. key figures

Previous close

USD 36.32 (2026-10-14)

1-year change

+62.7 %

Market cap

USD 1.75B

Enterprise value

USD 1.4B

P/E ratio (trailing)

-68.09

P/E ratio (forward)

-19.29

EPS (trailing)

-0.55

EPS (forward)

-1.94

PEG ratio

n/a

Price to book

4.42

Revenue growth

22,375.6 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

9.18

Employees

123

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Septerna, Inc.

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Septerna, Inc. and compare it with other stocks.